This is the authors' abstract. We don't add key points for this paper.
We present a new and sensitive fluorescent nanosensor for the direct determination of methimazole (MML) in human plasma samples. The strategy is based on fluorescence resonance energy transfer between amlodipine, an inexpensive pharmaceutical compound, as an energy donor and gold nanoparticles as an energy acceptor. The recovered fluorescence intensity in the presence of MML allows a direct and rapid quantitation of MML in human plasma samples with a detection limit of 0.15 ng/mL.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Abolhasani et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: